Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review

Background/Aims Membranous nephropathy (MN) is a major cause of nephrotic syndrome in adults. This study aimed to evaluate the effect of rituximab (RTX) in patients with idiopathic MN (iMN) who have a high risk of progression. Methods We retrospectively analyzed data of 13 patients with iMN, who rec...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Soo-Jee Jeon, Ji-Hye Kim, Hee-Won Noh, Ga-Young Lee, Jeong-Hoon Lim, Hee-Yeon Jung, Jang-Hee Cho, Ji-Young Choi, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Park
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	The Korean Association of Internal Medicine 2022-07-01
Edice:	The Korean Journal of Internal Medicine
Témata:	rituximab glomerulonephritis membranous proteinuria nephrotic syndrome immunosuppressive agents
On-line přístup:	http://kjim.org/upload/pdf/kjim-2021-155.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!